Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 10/10

vs
industry
vs
history
Cash to Debt No Debt
MSON's Cash to Debt is ranked higher than
99% of the 317 Companies
in the Global Medical Devices industry.

( Industry Median: 2.24 vs. MSON: No Debt )
Ranked among companies with meaningful Cash to Debt only.
MSON' s Cash to Debt Range Over the Past 10 Years
Min: 0.13  Med: 3.3 Max: No Debt
Current: No Debt
Equity to Asset 0.90
MSON's Equity to Asset is ranked higher than
94% of the 289 Companies
in the Global Medical Devices industry.

( Industry Median: 0.62 vs. MSON: 0.90 )
Ranked among companies with meaningful Equity to Asset only.
MSON' s Equity to Asset Range Over the Past 10 Years
Min: 0.5  Med: 0.74 Max: 0.91
Current: 0.9
0.5
0.91
Interest Coverage No Debt
MSON's Interest Coverage is ranked higher than
99% of the 223 Companies
in the Global Medical Devices industry.

( Industry Median: 69.16 vs. MSON: No Debt )
Ranked among companies with meaningful Interest Coverage only.
MSON' s Interest Coverage Range Over the Past 10 Years
Min: No Debt  Med: No Debt Max: No Debt
Current: No Debt
F-Score: 3
Z-Score: 11.70
M-Score: -2.17
WACC vs ROIC
2.84%
-53.48%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 4/10

vs
industry
vs
history
Operating margin (%) -17.92
MSON's Operating margin (%) is ranked lower than
66% of the 296 Companies
in the Global Medical Devices industry.

( Industry Median: 2.72 vs. MSON: -17.92 )
Ranked among companies with meaningful Operating margin (%) only.
MSON' s Operating margin (%) Range Over the Past 10 Years
Min: -35.87  Med: -15.8 Max: -4.22
Current: -17.92
-35.87
-4.22
Net-margin (%) 13.25
MSON's Net-margin (%) is ranked higher than
84% of the 296 Companies
in the Global Medical Devices industry.

( Industry Median: 1.43 vs. MSON: 13.25 )
Ranked among companies with meaningful Net-margin (%) only.
MSON' s Net-margin (%) Range Over the Past 10 Years
Min: -28.56  Med: -4.76 Max: 25.09
Current: 13.25
-28.56
25.09
ROE (%) 13.39
MSON's ROE (%) is ranked higher than
79% of the 296 Companies
in the Global Medical Devices industry.

( Industry Median: 1.21 vs. MSON: 13.39 )
Ranked among companies with meaningful ROE (%) only.
MSON' s ROE (%) Range Over the Past 10 Years
Min: -21.42  Med: -10.34 Max: 27.78
Current: 13.39
-21.42
27.78
ROA (%) 12.02
MSON's ROA (%) is ranked higher than
89% of the 318 Companies
in the Global Medical Devices industry.

( Industry Median: -0.39 vs. MSON: 12.02 )
Ranked among companies with meaningful ROA (%) only.
MSON' s ROA (%) Range Over the Past 10 Years
Min: -18.21  Med: -5.64 Max: 24.23
Current: 12.02
-18.21
24.23
ROC (Joel Greenblatt) (%) 0.28
MSON's ROC (Joel Greenblatt) (%) is ranked lower than
53% of the 312 Companies
in the Global Medical Devices industry.

( Industry Median: 4.23 vs. MSON: 0.28 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
MSON' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: -50.42  Med: -13.06 Max: 28.83
Current: 0.28
-50.42
28.83
Revenue Growth (3Y)(%) 7.00
MSON's Revenue Growth (3Y)(%) is ranked higher than
66% of the 232 Companies
in the Global Medical Devices industry.

( Industry Median: 3.80 vs. MSON: 7.00 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
MSON' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -35.3  Med: 5.9 Max: 36.3
Current: 7
-35.3
36.3
» MSON's 10-Y Financials

Financials (Next Earnings Date: Est. 2016-11-05)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q3 2015

MSON Guru Trades in Q3 2015

Jim Simons 162,697 sh (+16.46%)
» More
Q4 2015

MSON Guru Trades in Q4 2015

Jim Simons 162,600 sh (-0.06%)
» More
Q1 2016

MSON Guru Trades in Q1 2016

Jim Simons 166,000 sh (+2.09%)
» More
Q2 2016

MSON Guru Trades in Q2 2016

Jim Simons 171,000 sh (+3.01%)
» More
» Details

Insider Trades

Latest Guru Trades with MSON

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices
Compare:NAS:SPAN, AMEX:ELMD, NAS:AVGR, OTCPK:BTCY, OTCPK:PHMZF, OTCPK:QTVLF, NAS:NVCN, OTCPK:DIZTF, OTCPK:AVMXF, OTCPK:TLTFF, NAS:MGCD, NAS:CGNT, NAS:NVTR, NAS:RWLK, OTCPK:BSGM, OTCPK:ZMSPF, NAS:EDAP, NAS:AMDA, OTCPK:ELEAF, OTCPK:VASO » details
Traded in other countries:MX9.Germany,
Misonix Inc designs, manufactures, markets and develops minimally invasive ultrasonic surgical device products. Its products include the BoneScalpel surgical system, the SonaStar Surgical Aspirator and the SonicOne Wound Cleansing and Debridement System.

Misonix Inc a New York corporation organized in 1959. The Company designs, manufactures, markets and develops minimally invasive ultrasonic medical device products. These products include the BoneScalpel cutting system which is used among other things for surgical procedures of the spine and on Maxillofacial procedures, the SonaStar Surgical Aspirator which is used to emulsify and remove soft and hard tumors, the SonicOne Wound Cleansing and Debridement System which offers tissue specific debridement and cleansing of wounds for effective removal of devitalized tissue and fibrin deposits while sparing viable cells and the AutoSonix ultrasound cutting and coagulating system which is distributed and marketed for Misonix through Mentor Corporation, a subsidiary of Johnson & Johnson. The Company applications include the ability to transect or shape bone, ablate and aspirate both soft and hard tissue, cleanse and debridewounds and remove unwanted body fat. Among clinical specialties served are: Spine Surgery, Skull-Based Surgery (i.e., Cranio-Maxillo-Facial, Neurosurgery, Orthopedic Surgery and Plastic surgery). The Company sells its SonicOne Wound Cleansing and Debridement System, through direct sales persons and sales agents or distributors. The Companys main competitors are Johnson & Johnson, Valley Lab, a division of Tyco Healthcare, Integra Life Sciences, Inc., Sööring, and Stryker. The Companys medical device products are subject to the regulatory requirements of the U.S. Food and Drug Administration.

Ratios

vs
industry
vs
history
P/E(ttm) 16.71
MSON's P/E(ttm) is ranked higher than
72% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 27.51 vs. MSON: 16.71 )
Ranked among companies with meaningful P/E(ttm) only.
MSON' s P/E(ttm) Range Over the Past 10 Years
Min: 5.16  Med: 22.55 Max: 273
Current: 16.71
5.16
273
PE(NRI) 17.64
MSON's PE(NRI) is ranked higher than
69% of the 166 Companies
in the Global Medical Devices industry.

( Industry Median: 27.51 vs. MSON: 17.64 )
Ranked among companies with meaningful PE(NRI) only.
MSON' s PE(NRI) Range Over the Past 10 Years
Min: 11.64  Med: 20.32 Max: 200
Current: 17.64
11.64
200
Price/Owner Earnings (ttm) 62.87
MSON's Price/Owner Earnings (ttm) is ranked lower than
75% of the 108 Companies
in the Global Medical Devices industry.

( Industry Median: 31.29 vs. MSON: 62.87 )
Ranked among companies with meaningful Price/Owner Earnings (ttm) only.
MSON' s Price/Owner Earnings (ttm) Range Over the Past 10 Years
Min: 3.83  Med: 44.6 Max: 171.18
Current: 62.87
3.83
171.18
P/B 2.03
MSON's P/B is ranked higher than
64% of the 291 Companies
in the Global Medical Devices industry.

( Industry Median: 2.93 vs. MSON: 2.03 )
Ranked among companies with meaningful P/B only.
MSON' s P/B Range Over the Past 10 Years
Min: 0.26  Med: 1.47 Max: 5.84
Current: 2.03
0.26
5.84
P/S 2.15
MSON's P/S is ranked higher than
61% of the 284 Companies
in the Global Medical Devices industry.

( Industry Median: 3.21 vs. MSON: 2.15 )
Ranked among companies with meaningful P/S only.
MSON' s P/S Range Over the Past 10 Years
Min: 0.12  Med: 1.2 Max: 5.53
Current: 2.15
0.12
5.53
EV-to-EBIT 1468.32
MSON's EV-to-EBIT is ranked lower than
100% of the 161 Companies
in the Global Medical Devices industry.

( Industry Median: 22.46 vs. MSON: 1468.32 )
Ranked among companies with meaningful EV-to-EBIT only.
MSON' s EV-to-EBIT Range Over the Past 10 Years
Min: -212.1  Med: -6.7 Max: 1618.2
Current: 1468.32
-212.1
1618.2
EV-to-EBITDA 23.67
MSON's EV-to-EBITDA is ranked lower than
68% of the 170 Companies
in the Global Medical Devices industry.

( Industry Median: 18.25 vs. MSON: 23.67 )
Ranked among companies with meaningful EV-to-EBITDA only.
MSON' s EV-to-EBITDA Range Over the Past 10 Years
Min: -192.5  Med: -4.15 Max: 140.4
Current: 23.67
-192.5
140.4
Current Ratio 6.76
MSON's Current Ratio is ranked higher than
86% of the 310 Companies
in the Global Medical Devices industry.

( Industry Median: 2.51 vs. MSON: 6.76 )
Ranked among companies with meaningful Current Ratio only.
MSON' s Current Ratio Range Over the Past 10 Years
Min: 1.55  Med: 4.01 Max: 9.22
Current: 6.76
1.55
9.22
Quick Ratio 4.66
MSON's Quick Ratio is ranked higher than
81% of the 310 Companies
in the Global Medical Devices industry.

( Industry Median: 1.95 vs. MSON: 4.66 )
Ranked among companies with meaningful Quick Ratio only.
MSON' s Quick Ratio Range Over the Past 10 Years
Min: 0.76  Med: 2.96 Max: 7.5
Current: 4.66
0.76
7.5
Days Inventory 229.56
MSON's Days Inventory is ranked lower than
75% of the 277 Companies
in the Global Medical Devices industry.

( Industry Median: 133.25 vs. MSON: 229.56 )
Ranked among companies with meaningful Days Inventory only.
MSON' s Days Inventory Range Over the Past 10 Years
Min: 155.22  Med: 204.01 Max: 397.65
Current: 229.56
155.22
397.65
Days Sales Outstanding 63.81
MSON's Days Sales Outstanding is ranked higher than
56% of the 267 Companies
in the Global Medical Devices industry.

( Industry Median: 68.90 vs. MSON: 63.81 )
Ranked among companies with meaningful Days Sales Outstanding only.
MSON' s Days Sales Outstanding Range Over the Past 10 Years
Min: 60.37  Med: 69.65 Max: 94.8
Current: 63.81
60.37
94.8
Days Payable 72.00
MSON's Days Payable is ranked higher than
58% of the 259 Companies
in the Global Medical Devices industry.

( Industry Median: 58.34 vs. MSON: 72.00 )
Ranked among companies with meaningful Days Payable only.
MSON' s Days Payable Range Over the Past 10 Years
Min: 33.6  Med: 74.13 Max: 108.56
Current: 72
33.6
108.56

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -3.20
MSON's 3-Year Average Share Buyback Ratio is ranked higher than
53% of the 206 Companies
in the Global Medical Devices industry.

( Industry Median: -3.60 vs. MSON: -3.20 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
MSON' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -12.2  Med: -1.2 Max: 11.4
Current: -3.2
-12.2
11.4

Valuation & Return

vs
industry
vs
history
Price/Net Cash 8.94
MSON's Price/Net Cash is ranked higher than
68% of the 94 Companies
in the Global Medical Devices industry.

( Industry Median: 16.20 vs. MSON: 8.94 )
Ranked among companies with meaningful Price/Net Cash only.
MSON' s Price/Net Cash Range Over the Past 10 Years
Min: 1.88  Med: 11.11 Max: 86.83
Current: 8.94
1.88
86.83
Price/Net Current Asset Value 3.05
MSON's Price/Net Current Asset Value is ranked higher than
81% of the 201 Companies
in the Global Medical Devices industry.

( Industry Median: 7.35 vs. MSON: 3.05 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
MSON' s Price/Net Current Asset Value Range Over the Past 10 Years
Min: 0.72  Med: 3.06 Max: 8.6
Current: 3.05
0.72
8.6
Price/Tangible Book 2.27
MSON's Price/Tangible Book is ranked higher than
69% of the 264 Companies
in the Global Medical Devices industry.

( Industry Median: 4.28 vs. MSON: 2.27 )
Ranked among companies with meaningful Price/Tangible Book only.
MSON' s Price/Tangible Book Range Over the Past 10 Years
Min: 0.43  Med: 2.13 Max: 8.02
Current: 2.27
0.43
8.02
Price/Projected FCF 4.02
MSON's Price/Projected FCF is ranked lower than
73% of the 128 Companies
in the Global Medical Devices industry.

( Industry Median: 2.12 vs. MSON: 4.02 )
Ranked among companies with meaningful Price/Projected FCF only.
MSON' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.64  Med: 1.79 Max: 176.71
Current: 4.02
0.64
176.71
Price/Median PS Value 1.79
MSON's Price/Median PS Value is ranked lower than
85% of the 260 Companies
in the Global Medical Devices industry.

( Industry Median: 1.03 vs. MSON: 1.79 )
Ranked among companies with meaningful Price/Median PS Value only.
MSON' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.11  Med: 1.11 Max: 4.14
Current: 1.79
0.11
4.14
Price/Graham Number 1.34
MSON's Price/Graham Number is ranked higher than
67% of the 139 Companies
in the Global Medical Devices industry.

( Industry Median: 2.30 vs. MSON: 1.34 )
Ranked among companies with meaningful Price/Graham Number only.
MSON' s Price/Graham Number Range Over the Past 10 Years
Min: 0.56  Med: 1.66 Max: 7.81
Current: 1.34
0.56
7.81
Earnings Yield (Greenblatt) (%) 0.10
MSON's Earnings Yield (Greenblatt) (%) is ranked lower than
52% of the 305 Companies
in the Global Medical Devices industry.

( Industry Median: 0.60 vs. MSON: 0.10 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
MSON' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 0.1  Med: 2.6 Max: 5.1
Current: 0.1
0.1
5.1

More Statistics

Revenue (TTM) (Mil) $23.47
EPS (TTM) $ 0.38
Beta0.17
Short Percentage of Float0.16%
52-Week Range $3.83 - 12.00
Shares Outstanding (Mil)7.79
» More Articles for NAS:MSON

Headlines

Articles On GuruFocus.com
Weekly CFO Buys Highlight May 19 2013 
MISONIX Inc. (MSON) CEO Michael A Jr Mcmanus buys 5,000 Shares Dec 01 2009 
MISONIX Inc. Reports Operating Results (10-Q) Nov 16 2009 
MISONIX Inc. Reports Operating Results (10-K) Sep 28 2009 
MISONIX Inc. Reports Operating Results (10-Q) May 12 2009 

More From Other Websites
MISONIX INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and... Aug 26 2016
BoneScalpel® Hands-On Workshop Draws 20 Surgeons at the 2016 Scoliosis Research Society Worldwide... Aug 25 2016
BoneScalpel® Receives Positive Reception From Oral-Maxillofacial Surgeons at Major Taiwanese... Aug 23 2016
Misonix Supports Uganda Spine Mission For Fifth Consecutive Year Aug 11 2016
Misonix Supports Uganda Spine Mission For Fifth Consecutive Year Aug 11 2016
Misonix, Inc. Announces Exclusive Agreement with SonoSpine, LLC Aug 10 2016
Misonix, Inc. Announces Exclusive Agreement with SonoSpine, LLC Aug 10 2016
BoneScalpel® Hands-On Workshop Draws More Than 30 Surgeons at IMAST 2016 Meeting Jul 18 2016
Misonix, Inc.: Gathering momentum, can it sustain its performance? Jul 15 2016
Misonix SonicVac™ Recognized as a Top Innovation for Wound Care in Podiatry Jul 12 2016
Misonix SonicVac™ Recognized as a Top Innovation for Wound Care in Podiatry Jul 12 2016
BoneScalpel® Featured in the Lecture and Workshop at 9th Congress of the Chinese Association of... May 24 2016
BoneScalpel® Featured in the Lecture and Workshop at 9th Congress of the Chinese Association of... May 24 2016
BoneScalpel to be Featured at Master Techniques in Spine Surgery Workshop at Upcoming Ninth Congress... May 18 2016
BoneScalpel to be Featured at Master Techniques in Spine Surgery Workshop at Upcoming Ninth Congress... May 18 2016
Misonix Features New BoneScalpel® MIS at SpineWeek 2016 In Singapore May 16 2016
Misonix Features New BoneScalpel® MIS at SpineWeek 2016 In Singapore May 16 2016
MISONIX INC Financials May 14 2016
Misonix, Inc. :MSON-US: Earnings Analysis: Q3, 2016 By the Numbers May 13 2016
MISONIX INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... May 06 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)